|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Concurrent chemoradiation straegies in the management of unreseetable stage III non - small -cell lung cancer显示文摘 | Lara PN Goldberg Z DaviesA | 2002 | Clin Lung Cancer2002，2，： | 1 |
| 2 | Quality of life and the treatment of advanced lung cancer显示文摘 | Plunkett TA Chrystal KF Haryer PG | 2003 | Clin Lung Cancer2003，5，1： | 1 |
| 3 | Select clinical trials of erlotinib ( OSI- 774) in non-small-cell lung cancer with emphasis on phase III outcomes显示文摘 | Fuster LM Sandier AB | 2004 | Clin Lung Cancer2004，1，： | 1 |
| 4 | Endoscopic laser ablation as palliative treatment of endobronchial, nonresectable, or recurrent lung cancer: Assessment of its impact on quality of life 显示文摘 | Mantovani G Astara G Manca G | 2000 | Clin Lung Cancer2000，1，4： | 1 |
| 5 | Fragile histidine triad(FHIT)gene abnormalities in lung cancer显示文摘 | Zochbauer-Muller S Wistuba II Minna JD | 2000 | Clin Lung Cancer2000，2，2： | 1 |
| 6 | Management of advanced non-small-cell lu-ng cancer in elderly populations显示文摘 | Lilenbaum R | 2003 | Clin Lung Cancer2003，5，3： | 1 |
| 7 | Ceritinib (LDK378) : a potent al- ternative to crizotinib for ALK-rearranged non-small-cell lung cancer显示文摘 | LI S QI X HUANG Y | 2015 | Clin Lung Cancer2015，16，2： | 1 |
| 8 | Influence of sex on lung cancer histology, stage, and survival in a midwestern United Statestumor registry 显示文摘 | Ringer G Smith JM Engel AM | 2005 | Clin Lung Cancer2005，7，3： | 1 |
| 9 | Whole-brain radiation therapy plus concomitant temozolomide for the treatment of brain metastases from non-small-cell lung cancer: a randomized, open-label phase Ⅱ study显示文摘 | Chua D Krzakowski M Chouaid C | 2010 | Clin Lung Cancer2010，11，3： | 1 |
| 10 | DNA repair gene polymorphisms predict favorable clinical outcme in advanced non-small cell lung cancer 显示文摘 | Kalikaki A Kanaki M Vassalou H | 2009 | Clin Lung Cancer2009，10，2： | 1 |
| 11 | Clinical practice guiclelines for the treatment of unresectable non-small-cell 显示文摘 | Amercan Society of Clinical Oncology (ASCO) | 1997 | Lung cancer J clin Oncol1997，15，9： | 1 |
| 12 | Bevacizumab,when added to paclitaxel/carboplatin,prolongs survival in previously untreated petients with advanced non-small cell lung cancer:preliminary results from the ECOG 4599 trial显示文摘 | Tyagi P | 2005 | Clin Lung Cancer2005，6，2： | 1 |
| 13 | Human MOB1 ex- pression in non-small-cell lung cancer显示文摘 | Sasaki H Kawano O Endo K Suzuki E Yukiue H Kobayashi Y Yano M Fujii Y | 2007 | Clin Lung Cancer2007，8，4： | 1 |
| 14 | ERCC1, MLH1, MSH2, MSH6, and 13 IlI- Tubulin: Resistance proteins associated with response and outcome to platinum-based chemotherapy in malignant pleural mesothelioma显示文摘 | Ting Saskia | 2013 | Clin Lung Cancer2013，14，5： | 1 |
| 15 | Tumor BT- HI and BT-H3 expression in squamouscell carcinoma of the lung 显示文摘 | Boland JM Kwon ED Harrington SM | 2013 | Clin Lung Cancer2013，14，2： | 1 |
| 16 | A retrospective analysis of second line chemotherapy or best supportive care in patients with advanced stage non small-cell lung cancer显示文摘 | Hatzidaki D Agelaki S Mavroudis D | 2006 | Clin Lung Cancer2006，8，1： | 1 |
| 17 | Chemotherapy for brain metastases in small-cell lung cancer显示文摘 | Chen G Huynh M Chen A | 2008 | Clin Lung Cancer2008，9，1： | 1 |
| 18 | The impact of gefitinib on epidermal growth factor rec eptor signaling pathways in cancer 显示文摘 | Averbuch SD | 2003 | Clin Lung Cancer2003，1，： | 1 |
| 19 | Induction chemotherapy and late-course accelerated hyperfractionated radiation therapy for unresectable locally advanced non-small cell lung cancer:long term results of a phase Ⅰ/Ⅱ clinical trial显示文摘 | Chen M Chen YY Bao Y | 2005 | Clin Lung Cancer2005，6，： | 1 |
| 20 | Skeletal disease contributes substantially t o morbidity and mortality in patients with lung cancer显示文摘 | Hirsh V | 2009 | Clin Lung Cancer2009，10，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员